sulfonylurea vs glp 1 Mapping the effectiveness and risks of GLP-1 receptor agonists Diabetic Agents, From Metformin to
Description
Their efforts in improving affordability and access contribute to wider adoption
For more information contact us or book an appointment online
doi:10.1074/jbc.M109.033829
Bray, X
